News

Myricx Bio Enters into an Exclusive Antibody License Agreement...

Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase...

Chiesi, Haisco Partner on DPP1 Inhibitor for Respiratory Diseases

Chiesi Farmaceutici S.p.A, an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co. Ltd entered a licensing agreement to develop, manufacture, and commercialize...

Cryoport’s CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird...

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for...

The Role of Robotics in Urological Surgeries: Precision, Outcomes,...

The advancements in technology and the desire for minimally invasive surgeries have converged to propel the field of robotic urological surgeries to the forefront. As the...

Connected Devices Making Their Presence Felt In Pharma

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than...

Reference Approval Agencies Expanded By NPRA In Malaysia

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that have...

Symbiosis Pharmaceutical Services granted MHRA licence following a £1M...

Specialist Contract Development and Manufacturing Organisation (CDMO), Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read